CLINICAL_TRIALS
trial_result
· 2022-03-18
Clinical Trial Update: Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment [Phase 4]
Summary
Phase 4 clinical trial update evaluating susceptibility-guided therapy for Helicobacter pylori infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Shanghai Zhongshan Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN